The industry-first program aims to address the $50B in fall-related healthcare costs for older adults through a combination of innovative connected health devices, AI virtual assistance, predictive risk analytics, and support services.
Read MoreBeauty-Stem Biomedical, a cutting-edge stem cell supplement company, marked a momentous occasion with its grand opening in the vibrant city of Arcadia. The event was a resounding success, drawing health enthusiasts, researchers, and industry leaders from far and wide.
Read MoreIVUSE has revolutionized Atlanta's IV therapy landscape with unparalleled customer growth and the introduction of cutting-edge wellness and weight loss treatments, reaffirming its dedication to health innovation and personalized care.
Read MoreThe Food and Drug Administration approves CAR T-Cell therapy Carvykti® as a second-line treatment and the CAR T-Cell therapy Abecma® as a third-line treatment for adult patients with multiple myeloma.
Read MoreDuring Limb Loss and Limb Difference Awareness Month, Ottobock North America reaffirms its commitment to supporting the limb loss and limb difference community not just during April, but every day of the year.
Read MoreFollowing favorable FDA feedback for the treatment of liver disease, the company is preparing further pre-IND meetings with the FDA for the treatment of atherosclerosis and familial hypercholesterolemia
Read MoreDuring Limb Loss and Limb Difference Awareness Month, Ottobock North America reaffirms its commitment to supporting the limb loss and limb difference community not just during April, but every day of the year.
Read MoreThis additional funding comes at the heels of Selux announcing their third FDA 510(k) clearance on their direct from Positive Blood Culture Separator, making them the only single-platform technology capable of delivering rapid AST results for both positive blood culture and isolated colonies.
Read More